secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2024-12-27T23:59:59+00:00
Accession:  0001493152-24-052249
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology VP and COO Eric Forman resigns effective Dec 31, 2024
-------------------------------------------------------------------------

- Eric Forman resigned as VP and COO of Lixte Biotechnology Holdings, effective December 31, 2024.
- Resignation is for personal reasons; no disagreement with company operations, policies, or practices.
- Employment agreement dated July 15, 2020 (amended Aug 12, 2020 and Nov 6, 2022) terminates on Dec 31, 2024.
- No replacement or interim appointment has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315224052249/0001493152-24-052249-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315224052249/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-052249

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer